A significant shift is underway in small-molecule drug discovery, as a new collaboration between Ginkgo Datapoints, Tangible Scientific, and Inductive…
Read More
EClinical Solutions Study Models 241% ROI from AI-Powered Clinical Trial Data Platform
The intricate world of pharmaceutical research, particularly the demanding phases of clinical trials, stands at a pivotal juncture. Faced with…
Read More
A novel ‘asthma-on-a-chip’ platform breathes new life into study of the condition, offering hope for future treatments.
Engineers at the University of Pennsylvania (PA, USA) have engineered a groundbreaking human lung-on-a-chip technology, capable of replicating the intricate…
Read More
Bioengineered Bone Marrow Platform Offers New Frontier for Cancer Treatment Drug Testing and Deep Space Exploration
Researchers at the University of Pennsylvania School of Engineering and Applied Science, the Perelman School of Medicine, and the Children’s…
Read More
EClinical Solutions Study Models 241% ROI from AI-Powered Clinical Trial Data Platform
The landscape of clinical trials, a critical yet notoriously complex phase in drug development, is on the cusp of a…
Read More
AviadoBio Expands Exclusive Licensing of vMiX Gene-Silencing Platform to Encompass All Human Therapeutic Areas
AviadoBio has significantly broadened its strategic horizons through an expanded exclusive licensing agreement with King’s College London. This pivotal development…
Read More
EClinical Solutions Study Models 241% ROI from AI-Powered Clinical Trial Data Platform
A groundbreaking study, commissioned by eClinical Solutions and modeled by Hobson & Company, has unveiled compelling evidence of the transformative…
Read More
Innovative Bone Marrow-on-a-Chip Platform Developed by Penn and CHOP Researchers to Revolutionize Drug Testing and Aerospace Medicine
Deep within the skeletal framework of the human body lies a complex, high-performance factory: the bone marrow. This sponge-like tissue…
Read More
A Novel Drug Screening Platform Revolutionizes Approach to Neurological and Psychiatric Disorders by Targeting Protein Expression Imbalances
Researchers have developed an innovative drug screening platform designed to identify compounds that precisely target the primary cause of numerous…
Read More
Paradigm Health Launches SPIRE Platform to Revolutionize Post-Approval Oncology Research
The landscape of oncology therapeutics is rapidly evolving, with groundbreaking treatments continuously emerging and receiving regulatory approval. However, the journey…
Read More
